BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Methylnitronitrosoguanidine

A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties.

52+ PubMed studies analyzed · Evidence Score: 36.9

Research Domains

Methylnitronitrosoguanidine has been studied across 14 research domains including 🔬 Oncology, 🦠 Gut & Microbiome, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 54% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Methylnitronitrosoguanidine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Acetaldehyde
8 shared targets
Phenylthiourea
7 shared targets
Phenylglyoxal
5 shared targets
Toxaphene
10 shared targets
Arsenic
4 shared targets
Furazolidone
6 shared targets
Potassium
7 shared targets
acivicin
4 shared targets
Robenidine
5 shared targets
Lynestrenol
9 shared targets
Loading evidence profile...

This evidence profile for Methylnitronitrosoguanidine is generated deterministically from 52 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.